# Multiple Primary Malignancy-Related Gallbladder Cancer: An Important Recommendation for the Early Detection of Gallbladder Cancer

**Authors:** Hiroko Naganuma, Hideaki Ishida, Naoki Matsumoto, Masahiro Ogawa

PMC · DOI: 10.3390/diagnostics16040605 · 2026-02-19

## TL;DR

Gallbladder cancer often appears as a second cancer in patients with prior gastrointestinal cancer, and can occur without typical risk factors, suggesting the need for long-term monitoring and advanced imaging techniques for early detection.

## Contribution

Identifies gallbladder cancer as a frequent second malignancy in gastrointestinal cancer survivors, highlighting the role of contrast-enhanced ultrasonography for early detection.

## Key findings

- MPM-related gallbladder cancer commonly follows gastrointestinal cancers and occurs without typical risk factors like gallstones.
- Contrast-enhanced ultrasonography proved useful for detecting and diagnosing gallbladder cancer in MPM-positive cases.
- Long-term surveillance is recommended for cancer survivors to detect gallbladder cancer at a resectable stage.

## Abstract

Background: Gallbladder cancer (GBC) is a highly lethal malignancy that is often asymptomatic in its early stages and difficult to treat once clinical symptoms appear. Although established risk factors include female sex, gallstones, and chronic biliary inflammation, other clinical contexts associated with GBC remain insufficiently characterized. Multiple primary malignancies (MPMs), in which more than one primary cancer develops in the same individual, have recently attracted attention; however, their relationship with GBC has only rarely been examined. In this study, we aimed to clarify the clinical features of MPM-related GBC and explore its implications for early detection. Methods: We retrospectively compared 22 patients with GBC associated with other malignancies (MPM-positive GBC) and 16 patients with GBC alone (MPM-negative GBC). Clinical characteristics, major risk factors, tumor presentation, and imaging findings were evaluated. Special attention was paid to the sequence of cancer development and the diagnostic utility of contrast-enhanced ultrasonography (CEUS). Results: In all MPM-positive cases, GBC occurred as a second primary malignancy, most commonly following gastrointestinal cancers (12/22). Gallstones were significantly less frequent in the MPM-positive group than in the MPM-negative group (2/22 vs. 6/16). The MPM-positive group showed a slight male predominance (12 males and 10 females). Neither pancreaticobiliary maljunction nor porcelain gallbladder was identified in either group. CEUS was useful for both the detection and qualitative diagnosis of GBC in all patients. Conclusions: MPM-related GBC frequently develops as a second primary malignancy in patients with prior gastrointestinal cancer and may arise in the absence of classical risk factors. Careful long-term surveillance after cancer treatment is therefore essential for identifying second primary GBC at a potentially resectable stage. The combined use of ultrasonography and CEUS may facilitate earlier and more accurate diagnosis in this clinical setting.

## Linked entities

- **Diseases:** gallbladder cancer (MONDO:0003220)

## Full-text entities

- **Genes:** TENM1 (teneurin transmembrane protein 1) [NCBI Gene 10178] {aka ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1}
- **Diseases:** primary (MESH:D010538), choledochal cyst (MESH:D015529), T (MESH:D001260), gastrointestinal-gastrointestinal malignancies (MESH:D005767), von Hippel-Lindau syndrome (MESH:D006623), weight loss (MESH:D015431), gastric malignant lymphoma (MESH:D018442), polypoid (MESH:D000092342), colorectal cancer (MESH:D015179), viral infections (MESH:D014777), death (MESH:D003643), PSC (MESH:D015209), ICPNs (MESH:D002291), MPMs (MESH:D001932), chronic (MESH:D002908), breast cancer (MESH:D001943), congenital developmental anomalies (MESH:C566440), gastrointestinal cancer (MESH:D005770), Papillary adenocarcinoma of the gallbladder (MESH:D000231), adenocarcinoma (MESH:D000230), Gallstones (MESH:D042882), carcinoma in situ (MESH:D002278), GI cancers (MESH:D009369), diabetes mellitus (MESH:D003920), acute cholecystitis (MESH:D041881), rectal cancer (MESH:D012004), abdominal pain (MESH:D015746), porcelain gallbladder (MESH:C535889), gallbladder (MESH:D005705), fibrosis (MESH:D005355), chronic biliary inflammation (MESH:D007249), injury to (MESH:D014947), pancreatic cancer (MESH:D010190), hereditary syndromes (MESH:D009386), stage IIIb disease (MESH:C565555), obstruction (MESH:D000402), biliary stenosis (MESH:D003251), vomiting (MESH:D014839), cholangitis (MESH:D002761), mass (MESH:C536030), obesity (MESH:D009765), ) lesion (MESH:D009059), PBM (MESH:D000080222), nausea (MESH:D009325), gastric cancer (MESH:D013274), GBC (MESH:D005706), chronic inflammation of the gallbladder (MESH:D002764), carcinogenesis (MESH:D063646), Adenomas (MESH:D000236), jaundice (MESH:D007565)
- **Chemicals:** arsenic (MESH:D001151), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939306/full.md

---
Source: https://tomesphere.com/paper/PMC12939306